Captopril (Mylan Captopril)
Captopril
Viatris Healthcare (Pty) Ltd
Registration
- Applicant
- Viatris Healthcare (Pty) Ltd
- Certificate holder
- Viatris Healthcare (Pty) Ltd
- Registrations
- 2
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Mylan captopril 25 EACH TABLET CONTAINS CAPTOPRIL 25 mg | 12,5 mg/ 25 mg / 50 mgWhite capsule-shaped tablet | 29022829/7.1/0228Approved 18 October 2024 | Registered | S3 | PIPIL |
| Mylan captopril 50 EACH TABLET CONTAINS CAPTOPRIL 50,0 mg | 12,5 mg/ 25 mg / 50 mgWhite capsule-shaped tablet | 32052832/7.1/0528Approved 18 October 2024 | Registered | S3 | PIPIL |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Captopril
S3: Captopril
Consolidated Schedules 06 July 2026, line 3280
Pharmacological class: Vasodilators, hypotensive, antihypertensive medicines include other antihypertensive medicines e.g. ACE-inhibitors, ARBs, RAAS, etc] (class 7.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
(2S)-1-[(2S)-2-Methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid
Drag to rotate. Structure from PubChem CID 44093.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.